Evidence for control of complement receptor rosette-forming cells by alpha and beta-adrenergic agents.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D001665:Binding Sites / Q000187:drug effects*; D003994:Bucladesine / Q000494:pharmacology; D003165:Complement System Proteins / Q000378:metabolism*; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D007104:Immune Adherence Reaction; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA / Q000276:immunology; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013154:Spleen / Q000276:immunology
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000628:Aminophylline; D003994:Bucladesine; D003165:Complement System Proteins; D011433:Propranolol; D000262:Adenylyl Cyclases; D006152:Cyclic GMP; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine